Mawari's Public Decentralized Infrastructure Offering (DIO) to Launch with $45 Million Participation Volume
Mawari is conducting two distinct offerings: (1) a public Decentralized Infrastructure Offering (DIO) outside the United States under Regulation S, and (2) a U.S.-only offering through Republic under Rule 506(c) of Regulation D.
This public offering is made solely to non-U.S. persons in accordance with Regulation S under the U.S. Securities Act of 1933. U.S. persons may not participate except via the separate offering on Republic.
This communication is not directed to, and may not be acted upon by, U.S. persons or any person in a jurisdiction where participation in such offerings is not permitted.
Mawari, a pioneer in real‑time delivery of AI‑driven immersive 3D experiences, today unveiled its public Guardian Node Offering under the Decentralized Infrastructure Offering (DIO) model. The launch follows a multi-month effort that started in January 2025 and has been driven by a combination of strategic community engagement, early investor participation and public companies like GFA Co. Ltd., a private round from Japan which together have secured $45 million in node licenses committed to the network.
More than 139,492 Guardian Nodes have already been reserved, representing nearly half of the total 300,000 node supply.
'Nearly 140,000 Guardian Node licenses are already committed; proof that the community values nodes that do real work,' said Luis Oscar Ramirez, Founder & CEO of Mawari. 'Guardian Nodes validate every render, audit every metric, and keep latency, jitter, and quality in check across Mawari's Immersive Compute Network. By prioritizing measurable utility over hype, we're laying the infrastructure that will power the future of the immersive internet.'
The public DIO, launching on July 30th on nodes.mawari.net, will offer the remaining 160,508 Guardian Nodes to Non-U.S. participants only, pursuant to Regulation S under the U.S. Securities Act of 1933 (See terms here ).
Participants can purchase nodes using USDT and USDC on Arbitrum, with credit card payments available at a later date. Purchasers may also receive a unique referral code, enabling a promotional incentive for each invited friend who also buys (subject to other applicable rules and restrictions). All payments are on-chain and auditable, with bridging instructions provided to streamline access. Referral rewards are promotional in nature and do not constitute compensation for investment solicitation. Referral bonuses may include network credits, non-transferable badges, or other non-cash benefits.
Momentum continues to build across Mawari's ecosystem. Recently secured KDDI as an infrastructure provider and collaborated with Brave and Virtual Avex for VtuberXR, and its XR Chip, which 490,000 wallets have claimed, with over 2 million participants in the last month, as the Mawari Portal subscription base continues to grow.
Mawari's DIO network is redefining the node sale model, focusing on transparent utility over speculation. Unlike hype-driven launches, DIO follows a utility-first approach that prioritizes real participation and measurable network contributions. Guardian Node licenses are offered at a flat price, with operators earning rewards through active engagement. Node operators are responsible for maintaining network health and uptime and in return for verifiable participation, they may earn Network Monitoring Rewards that represent 20% of the Mawari Network's total utility rewards, alongside fixed incentives for early adopters who meet specified performance criteria.
Mawari, the world's first Immersive Compute Network, streams AI‑driven XR experiences globally in real time with near‑zero latency, seamlessly merging digital intelligence with physical reality to deliver lifelike 3D avatar agents.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Two additional Walgreens stores face state-licensing charges
The Walgreens store at John F Kennedy Road in Dubuque is facing possible sanctions from the Iowa Board of Pharmacy. (Photo via Google Earth) Two eastern Iowa Walgreens pharmacies are facing possible sanctions from state regulators. They are among six Walgreens stores to be charged this year with violating state regulations. The Iowa Board of Pharmacy has charged a Clinton Walgreens store and a Dubuque Walgreen store with failing to maintain accountability of controlled substances and records; failing to ensure accountability of Schedule III, IV and V controlled substances; failing to create and maintain complete and accurate records; and committing acts that render the store's Controlled Substances Act registration to be inconsistent with the public interest. The board has not disclosed the addresses of either store, but federal records indicate they are located at 1905 N. 2nd St. in Clinton and 55 John F. Kennedy Road in Dubuque. SUBSCRIBE: GET THE MORNING HEADLINES DELIVERED TO YOUR INBOX The board has not disclosed the alleged conduct that led to the filing of any of the charges. Hearings in the two cases are scheduled for Aug. 20, 2025. The charges against the two stores were imposed on May 8, 2025, but were only recently made public through a posting on a state website. In July, three Iowa Walgreens stores were fined by the Board of Pharmacy for medication-dispensing errors, two of which date back to early 2023. The three stores are located at 4600 86th St. in Urbandale, 5 E. Anson St. in Marshalltown, and 625 Pacha Parkway in North Liberty. In May, the board charged the Walgreens store at 3910 University Ave. in Waterloo with failing to maintain ultimate accountability of controlled substances and records; failing to ensure accountability of controlled substances; failing to create and maintain complete and accurate records as required by law; and committing acts that would render the store's Controlled Substances Act registration inconsistent with the public interest. The board has not publicly disclosed the alleged conduct that gave rise to the charges in that case or indicated when the conduct occurred. A board hearing in that case is scheduled for Sept. 24, 2025. In early 2024, eight Iowa Walgreens stores, all previously sanctioned by the state, were charged with violating pharmacy-recordkeeping regulations related to controlled substances. The stores involved in that case are located at 15601 Hickman Road in Clive; 901 N. Ankeny Boulevard in Ankeny; 3140 S.E. 14th St. in Des Moines; 2545 E. Euclid Ave. in Des Moines; 111 W. Ridgeway Ave. in Waterloo; 4555 Fleur Drive in Des Moines; 1251 4th St. in Mason City; and 12753 University Ave. in Clive. SUPPORT: YOU MAKE OUR WORK POSSIBLE Solve the daily Crossword
Business Insider
3 days ago
- Business Insider
Mawari Partners with Caldera to Launch Mawari Network, Enabling Real-Time Streaming of Immersive, AI-Powered Experiences Globally
Caldera, the internet of interconnected, modular blockchains, announced a partnership with Mawari, which is launching its network to power global infrastructure for real-time streaming of immersive 3D content. The partnership additionally positions Mawari Network to join Caldera's metalayer interoperability network, enhancing the platform's ability to deliver high-performance, low-latency AR/VR experiences worldwide. Mawari Network represents a breakthrough in decentralized physical infrastructure networks (DePIN), orchestrating storage, bandwidth, and rendering capabilities through a globally distributed network of GPU nodes. The platform's patented 3D streaming technology reduces bandwidth usage by 80% while ensuring seamless delivery of interactive, immersive, and contextually relevant spatial computing experiences. 'Caldera lets us persist stream-quality measurements—latency, jitter, dropped frames, and frame accuracy—on-chain in near real time,' said Luis Oscar Ramirez, Founder & CEO of Mawari. 'Guardian Nodes produce signed QoS attestations that are batched to the rollup; these records inform node reputation, routing, and reward calculations based on observed performance. Anchoring this loop on Caldera's high-throughput rollup makes our quality and usage data transparent and auditable for the Mawari Network ecosystem.' 'We're incredibly excited to have Mawari join the Caldera ecosystem,' said Matthew Katz, CEO of Caldera. 'Mawari is pioneering an entirely new application of blockchain technology for the delivery of XR content.' Proven Market Adoption Mawari's XR streaming technology is already being used by two of Japan's biggest VTuber agencies – Brave group and Virtual Avex. Together, they first showcased Mawari's vTubeXR product at the Expo 2025 Osaka, Kansai Japan in late May and each are part of Mawari's Early Access Program, designed to give Early Access Partners priority access to new features, dedicated onboarding support, and customizable monetization opportunities. Mawari plans to expand vTubeXR to a broader range of VTuber production companies and IP holders, supporting the evolution of both user experience and business models. Technical Innovation Meets Market Demand The Mawari Network utilizes two core technologies: Mawari's patented spatial streaming technology that works with Unity and Unreal Engine, and a strategically distributed network of edge computing nodes positioned near end-users. This architecture enables smooth AR/VR experiences on everyday devices by handling computationally intensive rendering remotely. With the extended reality market projected to exceed 100 million devices within five years, Mawari's DePIN approach democratizes participation by allowing anyone with GPU capacity to contribute to the network while earning rewards. Looking Forward The launch marks a significant milestone in bridging XR and Web3 technologies. Mawari Network's utility-based revenue model, backed by physical infrastructure and growing enterprise partnerships, positions the platform for sustainable growth across market cycles. About Caldera Caldera is the internet of blockchains, an ecosystem of modular, interconnected, and customizable chains. Caldera enables blockchain companies to launch their own scalable blockchains and interoperate with assets across hundreds of other ecosystems. Caldera secures $400M+ in total value and has processed 850M+ transactions across 27M+ unique addresses. About Mawari Mawari, the world's first Immersive Compute Network, streams AI‑driven XR experiences globally in real time with near‑zero latency, seamlessly merging digital intelligence with physical reality to deliver lifelike 3D avatar agents. Contact CEO
Business Wire
3 days ago
- Business Wire
Bolt Projects Announces $4.25 Million Private Placement
BERKELEY, Calif.--(BUSINESS WIRE)--Bolt Projects Holdings, Inc. (Nasdaq: BSLK) ('Bolt Projects' or the 'Company'), a developer of biomaterials for the beauty and personal care industry, today announced that it has entered into definitive agreements for the purchase and sale of an aggregate of 913,979 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $4.65 per share of common stock (or per pre-funded warrant in lieu thereof, less the nominal exercise price of $0.0001 per share) in a private placement priced at-the-market under Nasdaq rules. The private placement is expected to close on or about August 15, 2025, subject to the satisfaction of customary closing conditions. Bolt Projects Announces $4.25 Million Private Placement; Priced At-The-Market Under Nasdaq Rules Share Rodman & Renshaw LLC is acting as the exclusive placement agent for the offering. The gross proceeds from the offering are expected to be approximately $4.25 million, prior to deducting placement agent's fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering for working capital and other general corporate purposes. The securities described above are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the 'Securities Act'), and/or Regulation D promulgated thereunder and, along with the shares of common stock underlying the pre-funded warrants, have not been registered under the Securities Act, or applicable state securities laws. Accordingly, the securities issued in the private placement and shares of common stock underlying the pre-funded warrants may not be offered or sold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws. Pursuant to a registration rights agreement with investors, the Company has agreed to file a resale registration statement covering the securities described above. This press release shall not constitute an offer to sell or a solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction. About Bolt Projects Holdings Bolt Projects develops and produces innovative biomaterials for the beauty and personal care industry. The Company is built on biomaterials platforms that aim to disrupt and transform high-volume consumer goods industries. Bolt Projects is a pioneer in the consumer biomaterials space. The Company's Vegan Silk Technology Platform produces b-silk and other offerings for the beauty and personal care industry that are fully vegan and biodegradable. These versatile ingredients have been on the market since 2019. Its intellectual property portfolio is anchored by 77 granted patents and 118 pending patent applications. Forward-looking Statements This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the Securities Act of 1933, as amended (the 'Securities Act'), and Section 21E of the Securities Exchange Act of 1934, as amended (the 'Exchange Act'). All statements other than statements of historical facts contained in this communication, including, without limitation, statements regarding: statements related to the completion of the offering, the satisfaction of customary closing conditions related to the offering, and the intended use of proceeds therefrom. In some cases, you can identify forward-looking statements by terminology such as 'anticipate,' 'believe,' 'budget,' 'continue,' 'could,' 'estimate,' 'expect,' 'forecast,' 'intend,' 'may,' 'might,' 'plan,' 'possible,' 'potential,' 'predict,' 'project,' 'should,' 'strive,' 'will' or the negatives of these terms or variations of them or similar terminology although not all forward-looking statements contain these words. Forward-looking statements involve a number of risks, uncertainties, and assumptions, and actual results or events may differ materially from those projected or implied in those statements. Important factors that could cause such differences include, but are not limited to: market and other conditions, substantial doubt as to the Company's ability to continue as a going concern; the Company's history of net losses and negative cash flows; the Company's ability to generate sufficient cash to service its debt; the Company's ability to meet the continued listing requirements of Nasdaq and remain listed on a national stock exchange; the Company's ability to execute its business plan and adequately control its expenses or raise additional capital on favorable terms, if at all; the Company's dependence on sales of b-silk™ and xl-silk™ products from its Vegan Silk Technology Platform; the Company's reliance on a single or limited manufacturing partners and manufacturing facilities; reliance on manufacturing partners in regions that could be impacted by U.S. trade policy, including renegotiating or terminating existing trade agreements and leveraging tariffs; costs of and availability for its Vegan technology Platform products that are out of the Company's control; the Company's reliance on a single manufacturing partner and manufacturing facility for the production of its Vegan Silk Technology Platform product; pricing and availability for the Company's Vegan Silk Technology Platform products; market acceptance of from consumer product companies; the Company's ability to protect adequately its patents and other intellectual property assets; government regulations and private party actions relating to the marketing and advertising of cosmetic products that include the Company's Vegan Silk Technology Platform products or other products the Company develops; and the other risks and uncertainties discussed under the caption 'Risk Factors' included in the Company's Annual Report on Form 10-K for the fiscal year ended, December 31, 2024, as such factors may be updated from time to time in its other filings with the SEC, and accessible on the SEC's website at and the Investors section of the Company's website at www. The Company cautions you against placing undue reliance on forward-looking statements, which reflect current beliefs and are based on information currently available as of the date a forward-looking statement is made. Forward-looking statements set forth herein speak only as of the date they are made. The Company undertakes no obligation to revise forward-looking statements to reflect future events, changes in circumstances, or changes in beliefs, except as otherwise required by law.
